Skip to main content
. 2014 Apr 8;2014:437087. doi: 10.1155/2014/437087

Table 3.

Effects of single-pill amlodipine/atorvastatin-based therapy on glucose-lipid metabolism and inflammatory and oxidative stress markers.

Baseline Week 16
Glucose-lipid metabolism
 Fasting plasma glucose
 (mg/dL)
130 ± 51 127 ± 56
 Glycated hemoglobin (%) 6.1 ± 0.8 6.2 ± 0.9
 Total cholesterol (mg/dL) 230 ± 33 180 ± 37**
 LDL-cholesterol (mg/dL) 143 ± 27 97 ± 30**
 HDL-cholesterol (mg/dL) 63 ± 21 61 ± 19
 Triglycerides (mg/dL) 195 ± 140 180 ± 134
Inflammatory and oxidative stress markers
 hs-CRP (mg/dL) 0.18 ± 0.24 0.09 ± 0.10
 Serum pentosidine (μg/mL) 0.036 ± 0.013 0.046 ± 0.018**

Values are means ± SD. CRP: C-reactive protein. **P < 0.01.